Cargando…

Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease, characterized by distorted lung architecture and loss of respiratory function. Alveolar epithelial cell injury and hyperplasia, enhanced extracellular matrix deposition, and (myo)fibroblast activation are features of IPF. Wnt/β...

Descripción completa

Detalles Bibliográficos
Autores principales:	Königshoff, Melanie, Balsara, Nisha, Pfaff, Eva-Maria, Kramer, Monika, Chrobak, Izabella, Seeger, Werner, Eickelberg, Oliver
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374879/ https://www.ncbi.nlm.nih.gov/pubmed/18478089 http://dx.doi.org/10.1371/journal.pone.0002142

Ejemplares similares

Listen to the WNT; It Talks: WNT7A Drives Epithelial–Mesenchymal Cross-Talk within the Fibrotic Niche in Idiopathic Pulmonary Fibrosis
por: Königshoff, Melanie, et al.
Publicado: (2022)

Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis
por: Nikolova, Sevdalina, et al.
Publicado: (2010)

Correction to: Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis
por: Nikolova, Sevdalina, et al.
Publicado: (2022)

Validation of the 2(nd) Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis
por: Semren, Nora, et al.
Publicado: (2015)

Enolase 1 (ENO1) and protein disulfide-isomerase associated 3 (PDIA3) regulate Wnt/β-catenin-driven trans-differentiation of murine alveolar epithelial cells
por: Mutze, Kathrin, et al.
Publicado: (2015)

FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis
por: Al‐Tamari, Hamza M, et al.
Publicado: (2017)

Defining the Cell Types That Drive Idiopathic Pulmonary Fibrosis Using Single-Cell RNA Sequencing
por: Poczobutt, Joanna M., et al.
Publicado: (2019)

Human lung stem cells: Oh, the places you'll go!
por: Königshoff, Melanie, et al.
Publicado: (2011)

Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis
por: MacKenzie, BreAnne, et al.
Publicado: (2015)

WNT7B in fibroblastic foci of idiopathic pulmonary fibrosis
por: Meuten, Travis, et al.
Publicado: (2012)

Increased Primary Cilia in Idiopathic Pulmonary Fibrosis
por: Lee, Junguee, et al.
Publicado: (2018)

Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF)
por: Krauss, Ekaterina, et al.
Publicado: (2019)

Alveolar fluid clearance in acute lung injury: what have we learned from animal models and clinical studies?
por: Morty, Rory E., et al.
Publicado: (2007)

Pivotal Role of Matrix Metalloproteinase 13 in Extracellular Matrix Turnover in Idiopathic Pulmonary Fibrosis
por: Nkyimbeng, Takwi, et al.
Publicado: (2013)

‘WNT-er is coming’: WNT signalling in chronic lung diseases
por: Baarsma, H A, et al.
Publicado: (2017)

Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis
por: Machahua, Carlos, et al.
Publicado: (2016)

NHLRC2 expression is increased in idiopathic pulmonary fibrosis
por: Kreus, Mervi, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Wnt Pathway Activation in Long Term Remnant Rat Model
por: Banon-Maneus, E., et al.
Publicado: (2014)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Distinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
por: Shi, Juan, et al.
Publicado: (2017)

Profibrotic role of WNT10A via TGF-β signaling in idiopathic pulmonary fibrosis
por: Oda, Keishi, et al.
Publicado: (2016)

Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis
por: Witt, Sabine, et al.
Publicado: (2019)

Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis
por: Buendía-Roldán, Ivette, et al.
Publicado: (2016)

Aberrant nonfibrotic parenchyma in idiopathic pulmonary fibrosis is correlated with decreased β‐catenin inhibition and increased Wnt5a/b interaction
por: Rydell‐Törmänen, Kristina, et al.
Publicado: (2016)

Noncanonical WNT-5A signaling impairs endogenous lung repair in COPD
por: Baarsma, Hoeke A., et al.
Publicado: (2017)

Induced pluripotent stem cells modulate the Wnt pathway in the bleomycin-induced model of idiopathic pulmonary fibrosis
por: Bayati, Paria, et al.
Publicado: (2023)

Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis
por: Korfei, Martina, et al.
Publicado: (2018)

Correction: Noncanonical WNT-5A signaling impairs endogenous lung repair in COPD
por: Baarsma, Hoeke A., et al.
Publicado: (2017)

Smoking and Idiopathic Pulmonary Fibrosis
por: Oh, Chad K., et al.
Publicado: (2012)

Autophagy in Idiopathic Pulmonary Fibrosis
por: Patel, Avignat S., et al.
Publicado: (2012)

The treatment of idiopathic pulmonary fibrosis
por: Woodcock, Hannah V., et al.
Publicado: (2014)

Epidemiology of idiopathic pulmonary fibrosis
por: Ley, Brett, et al.
Publicado: (2013)

IPF - Idiopathic Pulmonary Fibrosis
Publicado: (2019)

Management of Idiopathic Pulmonary Fibrosis
por: Pleasants, Roy, et al.
Publicado: (2019)

Treatment of Idiopathic Pulmonary Fibrosis
por: Abuserewa, Sherif T, et al.
Publicado: (2021)

Cough in Idiopathic Pulmonary Fibrosis
por: Mann, Jennifer, et al.
Publicado: (2021)

Cough in idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2016)

Idiopathic Pulmonary Fibrosis and Telomeres
por: Mulet, Alba, et al.
Publicado: (2022)

Living with idiopathic pulmonary fibrosis
por: Kirby, Tony
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rpbje6cr8adlp08ecef11m2tf8